Ending AIDS in the Asia–Pacific region by 2030: are we on track? Policy, epidemiological and intervention insights
Kimberly Green A , Heather-Marie A. Schmidt B C , Andrew J. Vallely D E , Lei Zhang
F G H , Angela Kelly-Hanku D E , Rena Janamnuaysook I J and Jason J. Ong F G K L
A PATH, Hanoi, Vietnam.
B UNAIDS, Asia and the Pacific, Bangkok, Thailand.
C World Health Organization, Geneva, Switzerland.
D University of New South Wales, Sydney, NSW, Australia.
E Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
F Central Clinical School, Monash University, Melbourne, Vic., Australia.
G China–Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, 710061, PR China.
H Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou 450001, Henan, China.
I Institute of HIV Research and Innovation, Bangkok, Thailand.
J Center of Excellence in Transgender Health, Chulalongkorn University, Bangkok, Thailand.
K London School of Hygiene and Tropical Medicine, London, UK.
L Corresponding author. Email: doctorjasonong@gmail.com
Sexual Health 18(1) 1-4 https://doi.org/10.1071/SH20226
Submitted: 22 December 2020 Accepted: 23 December 2020 Published: 5 March 2021
Abstract
The Asia–Pacific region is home to nearly 6 million people living with HIV. Across the region, key populations – men who have sex with men, transgender women, people who inject drugs, sex workers, prisoners – and their sexual partners make up the majority of those living with HIV. While significant progress has been made in the past 5 years towards UNAIDS’s 90–90–90 goals (90% of people with HIV diagnosed, 90% on antiretroviral therapy, 90% virologically suppressed), significant gaps remain. The papers in this Special Issue address important questions: are we on track to end the AIDS epidemic in the Asia–Pacific region? And can countries in this region reach the new UNAIDS targets for 2030?
Keywords: Asia, Asia–Pacific region, community-led health services, epidemic, HIV/AIDS, key populations, prevention intervention, vulnerable populations.
References
[1] Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS data 2020. 2020. Available online at: https://www.unaids.org/sites/default/files/media_asset/2020_aids-data-book_en.pdf [verified 22 November 2020].[2] Joint United Nations Programme on HIV/AIDS. Prevailing against pandemics by putting people at the centre. 2020. Available online at: https://www.unaids.org/sites/default/files/media_asset/prevailing-against-pandemics_en.pdf [verified 17 December 2020].
[3] Zablotska IB, Baeten JM, Phanuphak N, McCormack S, Ong J. Getting pre-exposure prophylaxis (PrEP) to the people: opportunities, challenges and examples of successful health service models of PrEP implementation. Sex Health 2018; 15 481–4.
| Getting pre-exposure prophylaxis (PrEP) to the people: opportunities, challenges and examples of successful health service models of PrEP implementation.Crossref | GoogleScholarGoogle Scholar | 30496716PubMed |
[4] Phanuphak N, Sungsing T, Jantarapakde J, Pengnonyang S, Trachunthong D, Mingkwanrungruang P, et al Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand. Sex Health 2018; 15 542–55.
| Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand.Crossref | GoogleScholarGoogle Scholar | 30249317PubMed |
[5] Green KE, Vu BN, Phan HTT, Tran MH, Ngo HV, Vo SH, et al From conventional to disruptive: upturning the HIV testing status quo among men who have sex with men in Vietnam. J Int AIDS Soc 2018; 21 e25127
| From conventional to disruptive: upturning the HIV testing status quo among men who have sex with men in Vietnam.Crossref | GoogleScholarGoogle Scholar | 30033557PubMed |
[6] De Abreu Lourenço R, Devlin N, Howard K, Ong JJ, Ratcliffe J, Watson J, et al Giving a voice to marginalised groups for health care decision making. Patient 2021; 14 5–10.
| Giving a voice to marginalised groups for health care decision making.Crossref | GoogleScholarGoogle Scholar | 33000424PubMed |
[7] McMahon JH, Hoy JF, Kamarulzaman A, Bekker LG, Beyrer C, Lewin SR. Leveraging the advances in HIV for COVID-19. Lancet 2020; 396 943–4.
| Leveraging the advances in HIV for COVID-19.Crossref | GoogleScholarGoogle Scholar | 33010825PubMed |
[8] Banerjee S, Chan R. Crafting a Community Blueprint towards ending HIV transmission and AIDS in Singapore by 2030. Sex Health 2021; 18 116–18.
[9] Murphy E, Shwe YY, Bhatia R, Bakkali T, Vannakit R. What will it take to end AIDS in Asia and the Pacific region by 2030? Sex Health 2021; 18 41–9.
[10] van Griensven F, de Lind van Wijngaarden JW, Eustaquio PC, Wignall S, Azwa I, Veronese V, et al The continuing HIV epidemic among men who have sex with men and transgender women in the ASEAN region: implications for HIV policy and service programming. Sex Health 2021; 18 21–30.
[11] Blondell SJ, Debattista J, Griffin MP, Durham J. ‘I think they might just go to the doctor’: qualitatively examining the (un)acceptability of newer HIV testing approaches among Vietnamese-born migrants in greater-Brisbane, Queensland, Australia. Sex Health 2021; 18 50–7.
[12] Whitford K, Mitchell E, Lazuardi E, Rowe E, Tasya IA, Wirawan DN, et al A strengths-based analysis of social influences that enhance HIV testing among female sex workers in urban Indonesia. Sex Health 2021; 18 77–83.
[13] O’Connor C, Leyritana K, Calica K, Gill R, Doyle AM, Lewis JJ, et al Risk factors affecting adherence to antiretroviral therapy among HIV patients Manila, Philippines: a baseline cross-sectional analysis of the Philippines Connect for Life Study. Sex Health 2021; 18 95–103.
[14] Liang H, Tang K, Cao W, Guo Y, Jiao Y, Zhu W, et al Factors influencing the acceptability of HIV/AIDS voluntary counselling and testing: a quantitative study of 41 336 female university students in China. Sex Health 2021; 18 119–21.
[15] Ye R, Liu C, Tan S, Li J, Simoni JM, Turner D, et al Factors associated with past HIV testing among men who have sex with men attending university in China: a cross-sectional study. Sex Health 2021; 18 58–63.
[16] Ruan L, Zhao R, Ong JJ, Fu X, Xiong Y, Chen Y, et al A national survey of HIV knowledge, sexual practices and attitude towards homosexuality for HIV elimination among young people in China. Sex Health 2021; 18 64–76.
[17] Janamnuaysook R, Green KE, Seekaew P, Vu BN, Ngo HV, Doan HA, Pengnonyang S, et al Demedicalisation of HIV interventions to end HIV in the Asia–Pacific. Sex Health 2021; 18 13–20.
[18] Srinivas ML, Ritchwood TD, Zhang TP, Li J, Tucker JD. Social innovation in sexual health: a scoping review towards ending the HIV epidemic. Sex Health 2021; 18 5–12.
[19] Haldar P, Reza-Paul S, Daniel RA, Lazarus L, Rewari BB, Lorway R, et al A rapid review of pre-exposure prophylaxis for HIV in the Asia–Pacific region: recommendations for scale up and future directions. Sex Health 2021; 18 31–40.
[20] Newland J, Lestari D, Poedjanadi MN, Kelly-Hanku A. Co-locating art and health: engaging civil society to create an enabling environment to respond to HIV in Indonesia. Sex Health 2021; 18 84–94.
[21] Green KE, Nguyen LH, Phan HTT, Vu BN, Tran MH, Ngo HV, et al Prepped for PrEP? Acceptability, continuation and adherence among men who have sex with men and transgender women enrolled as part of Vietnam’s first pre-exposure prophylaxis program. Sex Health 2021; 18 104–15.
